You see, this is the type of post which doesn’t sit well with me. How is the current market cap irrelevant? If it’s a sham today, it’s a sham down the road... You guys are giving Gerald a pass and it really is a terrible thing. EMOR’s revs/cash cannot support an emerging biotech company and it’s obvious. They will never, at the current rate, be able to pay ambs, what they have agreed to